✦ LIBER ✦

Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy

✍ Scribed by T. J. Garrett; Ronald E. Drusin; Larry L. Schulman; Dennis S. Reison; Amy Chadburn; Daniel M. Knowles; Mark L. Barr; Jonathan M. Chen; Craig R. Smith; Eric A. Rose; Robert E. Michler

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 422 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931101)72:9<2782::aid-cncr2820720941>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with etoposide, vincristine

Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma

✍ Gorgun Akpek; Howard K. Koh; Steven Bogen; Carl O'Hara; Francine M. Foss 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lymphoma (CTCL). ## METHODS. Fifteen patients were tre

Concomitant cyclophosphamide, doxorubici

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

✍ Emanuela Vaccher; Michele Spina; Giampiero di Gennaro; Renato Talamini; Guglielm 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Adriamycin, dibromodulcitol, and mitomyc

Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone

✍ Kavitha Pinnamaneni; Hwee-Yong Yap; Aman U. Buzdar; Alfred Distefano; George R. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

A medical research council randomized tr

A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma : Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy

✍ Graham M. Mead; Norman M. Bleehen; Anna Gregor; Jill Bullimore; D. Shirley Murre 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

Dose-escalated cyclophosphamide, doxorub

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma : Cancer and Leukemia Group B studies 8852 and 8854

✍ Nancy L. Bartlett; Gina R. Petroni; Barbara A. Parker; Nina D. Wagner; Jon P. Go 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Hybrid chemotherapy consisting of cyclop

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease

✍ Silvia Montoto; Mireia Camós; Armando López-Guillermo; Francesc Bosch; Francisco 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## BACKGROUND. Combination chemotherapy, including hybrid regimens, is the standard treatment for patients with advanced Hodgkin disease (HD). Although a prolonged complete response (CR) is achieved in up to 70 -80% of patients, long term complications, such as secondary leukemia, are of concern. C